TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TORNTPHARM Stock 12 Month Forecast
There Are No Analyst Ratings for IN:TORNTPHARM In The Last 3 Months.
Highest Price Target―
Average Price Target―
Lowest Price Target―
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
TORNTPHARM Financial Forecast
TORNTPHARM Earnings Forecast
Next quarter’s earnings estimate for TORNTPHARM is ₹20.22 with a range of ₹11.06 to ₹29.50. The previous quarter’s EPS was ₹19.00. TORNTPHARM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year TORNTPHARM has Performed in-line its overall industry.
Next quarter’s earnings estimate for TORNTPHARM is ₹20.22 with a range of ₹11.06 to ₹29.50. The previous quarter’s EPS was ₹19.00. TORNTPHARM beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year TORNTPHARM has Performed in-line its overall industry.
TORNTPHARM Sales Forecast
Next quarter’s sales forecast for TORNTPHARM is ₹39.56B with a range of ₹33.93B to ₹42.05B. The previous quarter’s sales results were ₹33.03B. TORNTPHARM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year TORNTPHARM has Performed in-line its overall industry.
Next quarter’s sales forecast for TORNTPHARM is ₹39.56B with a range of ₹33.93B to ₹42.05B. The previous quarter’s sales results were ₹33.03B. TORNTPHARM beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year TORNTPHARM has Performed in-line its overall industry.
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.
TORNTPHARM Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
0
0
0
0
0
In the current month, TORNTPHARM has received 0Buy Ratings, 0Hold Ratings, and 0Sell Ratings. TORNTPHARM average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
TORNTPHARM Stock Forecast FAQ
What is IN:TORNTPHARM’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:TORNTPHARM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:TORNTPHARM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Torrent Pharmaceuticals Ltd a Buy, Sell or Hold?
Currently, no data Available
What is Torrent Pharmaceuticals Ltd’s share price target?
Currently, no data Available
What do analysts say about Torrent Pharmaceuticals Ltd?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Torrent Pharmaceuticals Ltd?
To buy shares of IN:TORNTPHARM, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.